Zhao Jinglu, Zhu Yun, Xie Xiaoli, Yao Yuxiao, Zhang Jiao, Zhang Ruizhong, Huang Lihua, Cheng Jiwen, Xia Huimin, He Jing, Zhang Yan
Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzho, Guangdong 510623, China.
Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzho, Henan 450052, China.
Aging (Albany NY). 2019 Feb 22;11(4):1252-1261. doi: 10.18632/aging.101834.
Hirschsprung disease (HSCR) is a heterogeneous congenital disorder that affects the enteric nervous system, while neuroblastoma is an embryonal tumor of the sympathetic nervous system. Familial cases of both HSCR and neuroblastoma appear to be functionally linked to , which plays a key role in the development of neural crest derivatives. However, the association between common variants and disease risk is contested. Additionally, large-scale examination for pleiotropy or shared genetic susceptibility in sporadic HSCR and neuroblastoma cases lacks theoretical support. Here, we report the first examination of in 1470 HSCR and 469 neuroblastoma patients with matched healthy controls. The rs28647582 polymorphism was found to be associated with HSCR (P = 2.21E-03, OR = 1.26), and each subtype of the ailment (3.22E-03 ≤ P ≤ 0.43, 1.11 ≤ OR ≤ 2.32). The association between rs28647582 and NB risk was consistent with HSCR in a recessive model, though the P value was marginal (P = 0.06). These new genetic findings indicate the potential pleiotropic effects of in both HSCR and neuroblastoma, which could guide the development of therapeutic targets for the treatment of related neurodevelopmental disorders.
先天性巨结肠症(HSCR)是一种影响肠神经系统的异质性先天性疾病,而神经母细胞瘤是交感神经系统的一种胚胎性肿瘤。HSCR和神经母细胞瘤的家族病例似乎在功能上与[此处原文缺失相关基因名称]相关联,该基因在神经嵴衍生物的发育中起关键作用。然而,常见变异与疾病风险之间的关联存在争议。此外,对散发性HSCR和神经母细胞瘤病例的多效性或共同遗传易感性进行大规模检查缺乏理论支持。在此,我们报告了对1470例HSCR患者和469例神经母细胞瘤患者以及匹配的健康对照进行的首次[此处原文缺失相关基因名称]检查。发现rs28647582多态性与HSCR相关(P = 2.21E - 03,OR = 1.26),并且与该疾病的每个亚型相关(3.22E - 03 ≤ P ≤ 0.43,1.11 ≤ OR ≤ 2.32)。在隐性模型中,rs28647582与NB风险之间的关联与HSCR一致,尽管P值处于临界值(P = 0.06)。这些新的遗传发现表明[此处原文缺失相关基因名称]在HSCR和神经母细胞瘤中可能具有多效性作用,这可为治疗相关神经发育障碍的治疗靶点开发提供指导。